Arkom Cheirsilpa

Direttore/Membro del Consiglio presso THAI NAKARIN HOSPITAL

76 anni

Consumer Services

Health Services

Miscellaneous

Profilo

Arkom Cheirsilpa is a professional with an MBA from the University of Chulalongkorn and an undergraduate degree from Mahidol University.
He is currently a Non-Executive Director & Director-Holistic at Thai Nakarin Hospital Public Co. Ltd.
since 2008.
Prior to this, he was the Deputy Director at National Cancer Institute from 2002 to 2007.

Posizioni attive di Arkom Cheirsilpa

Società	Posizione	Inizio
THAI NAKARIN HOSPITAL	Direttore/Membro del Consiglio	20/11/2008

Tutte le posizioni attive di Arkom Cheirsilpa

Precedenti posizioni note di Arkom Cheirsilpa

Società	Posizione	Fine
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.	Corporate Officer/Principal	01/01/2007

Vedi nel dettaglio l'esperienza di Arkom Cheirsilpa

Formazione di Arkom Cheirsilpa

Mahidol University	Undergraduate Degree
University of Chulalongkorn	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Arkom Cheirsilpa

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
THAI NAKARIN HOSPITAL	Health Services

Aziende private	1
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.	Miscellaneous